• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
  • INW Senior
Home » Evergreen Bioscience incubator lands first tenant

Evergreen Bioscience incubator lands first tenant

Spokane-based Glyciome awarded $2.3M from National Cancer Institute

Glyciome_web.jpg

Glyciome LLC, led by CEO Joanna Ellington, is the first company to move into Evergreen Bioscience Innovation Cluster's business incubator. 

| Glyciome LLC
September 25, 2025
Karina Elias

Evergreen Bioscience Innovation Cluster has landed its first business incubator tenant while simultaneously securing a Community Impact Grant from Rotary Club of Spokane 21, says Executive Director Michaele Armstrong.

Biotech startup Glyciome LLC is the first company to move into Evergreen Bio’s new bioscience business incubator, located at 10220 N. Nevada, in Spokane. The 5,000-square-foot facility can accommodate between three and five companies, Armstrong notes, adding she’s currently in negotiations with a second company and beginning talks with a third.

With Rotary Club’s $1,960 investment into the incubator’s collaborative structure, Armstrong says she feels validated in the organization’s promise and footing.

“Glyciome’s trust and Rotary’s investment show how regional partnerships can turn constrained forces into powerful outcomes that no single organization could achieve alone,” Armstrong says in a statement.

Glyciome is a biotech startup led by co-founders Joanna Ellington, Ph.D., and Dennis Clifton, doctor of pharmacy. Established in 2018, the company is pioneering therapeutics that address the connection between microbiota and cancer, and advancing genital health in critical areas like cervical and penile cancer, says Ellington. 

This month, the Spokane-based company was awarded a $2.3 million grant from the National Cancer Institute, an arm of the National Institutes of Health. The capital will fund Glyciome’s Phase II clinical trials to commercialize the company’s patented, prebiotic, personal lubricant. The product helps keep good bacteria and gets rid of bad bacteria, Ellington explains.

“It hasn’t been easy,” Ellington says, noting that National Cancer Institute funding was stalled in January, just days before the company was supposed to receive its grant.

Previously, in 2023, the company completed its National Cancer Institute Phase I trial for a cervical cancer prevention probiotic device. The following year, they received a $455,000 matching grant from the Health Sciences & Services Authority of Spokane County.  

“We’re so grateful to HSSA,” she says. “The funding helped keep our lights on. We never would have made it with the gap in funding.”

Glyciome is the second company Ellington has founded. In the 90s, she also founded Bio-OriGyn LLC, which developed a pre-seed vaginal lubricant for couples with fertility issues. Ellington says the product became a national best-seller. She later sold Bio-OriGyn to an international company.

    Latest News Health Care
    • Related Articles

      Evergreen Bioscience envisions new bioscience building, sets sights on larger goals

      Meet & Greet: Michaele Armstrong, Executive Director, Evergreen Bioscience Innovation Cluster

      Catching up with: Michaele Armstrong, executive director of Evergreen Bioscience Innovation Cluster

    • Related Products

      Market Fact Book PDF

    3ad05d77f20feb803d3db3a699fb8758
    Karina Elias

    Construction underway at Hazzard Business Park

    More from this author
    Daily News Updates

    Subscribe today to our free E-Newsletters!

    Subscribe

    Featured Poll

    How much are you spending on holiday shopping this year?

    Popular Articles

    • Fratello web
      By Tina Sulzle

      Fratello's opens to strong demand in Kendall Yards

    • Concrete a web
      By Karina Elias

      Lodging comes to Silverwood

    • By Tina Sulzle

      Trader Joe's puts forward plans in Spokane Valley

    • Hht 3 web
      By Karina Elias

      Kaiser completes $25M expansion at Trentwood

    • Vintage (10) c
      By Tina Sulzle

      Aloha Vintage marketplace opens in Millwood

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2025 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing